Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects.

MLA

Wang, Yufei, et al. “Affinity Fine-Tuning Anti-CAIX CAR-T Cells Mitigate on-Target off-Tumor Side Effects.” Molecular Cancer, vol. 23, no. 1, Mar. 2024, p. 56. EBSCOhost, https://doi.org/10.1186/s12943-024-01952-w.

APA

Wang, Y., Buck, A., Piel, B., Zerefa, L., Murugan, N., Coherd, C. D., Miklosi, A. G., Johal, H., Bastos, R. N., Huang, K., Ficial, M., Laimon, Y. N., Signoretti, S., Zhong, Z., Hoang, S.-M., Kastrunes, G. M., Grimaud, M., Fayed, A., Yuan, H.-C., … Marasco, W. A. (2024). Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects. Molecular Cancer, 23(1), 56. https://doi.org/10.1186/s12943-024-01952-w

Chicago

Wang, Yufei, Alicia Buck, Brandon Piel, Luann Zerefa, Nithyassree Murugan, Christian D Coherd, Andras G Miklosi, et al. 2024. “Affinity Fine-Tuning Anti-CAIX CAR-T Cells Mitigate on-Target off-Tumor Side Effects.” Molecular Cancer 23 (1): 56. doi:10.1186/s12943-024-01952-w.